Selected research
Industry Growth & Trends
Global Drugs For Travelers' Diarrhea (TD) Industry Growth and Trends Forecast to 2032
Market perspective
The global Drugs For Travelers' Diarrhea (TD) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Drugs For Travelers' Diarrhea (TD) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Drugs For Travelers' Diarrhea (TD) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Drugs For Travelers' Diarrhea (TD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Drugs For Travelers' Diarrhea (TD) include Sun Pharmaceutical Industries Ltd., Johnson & Johnson, Bayer AG, Valneva SE, Perrigo Company Plc, Norgine, Immuron, COSMO PHARMACEUTICALS and Bausch Health Companies Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Drugs For Travelers' Diarrhea (TD) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Drugs For Travelers' Diarrhea (TD) market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Drugs For Travelers' Diarrhea (TD) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Drugs For Travelers' Diarrhea (TD).
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Drugs For Travelers' Diarrhea (TD) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Drugs For Travelers' Diarrhea (TD) Market by Company
Sun Pharmaceutical Industries Ltd.
Johnson & Johnson
Bayer AG
Valneva SE
Perrigo Company Plc
Norgine
Immuron
COSMO PHARMACEUTICALS
Bausch Health Companies Inc.
Drugs For Travelers' Diarrhea (TD) Segment by Type
Antidiarrheal Agents
Oral Rehydration Therapy (ORS)
Antibiotics
Others
Drugs For Travelers' Diarrhea (TD) Segment by Application
Adults
Children
Drugs For Travelers' Diarrhea (TD) Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs For Travelers' Diarrhea (TD) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drugs For Travelers' Diarrhea (TD) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs For Travelers' Diarrhea (TD).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drugs For Travelers' Diarrhea (TD) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Drugs For Travelers' Diarrhea (TD) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Antidiarrheal Agents
- Oral Rehydration Therapy (ORS)
- Antibiotics
- Others
Applications
- Adults
- Children
Companies covered
- Sun Pharmaceutical Industries Ltd.
- Johnson & Johnson
- Bayer AG
- Valneva SE
- Perrigo Company Plc
- Norgine
- Immuron
- COSMO PHARMACEUTICALS
- Bausch Health Companies Inc.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Drugs For Travelers' Diarrhea (TD) Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Drugs For Travelers' Diarrhea (TD) Sales Estimates and Forecasts (2021-2032)
- 1.3 Drugs For Travelers' Diarrhea (TD) Market by Type
- 1.3.1 Antidiarrheal Agents
- 1.3.2 Oral Rehydration Therapy (ORS)
- 1.3.3 Antibiotics
- 1.3.4 Others
- 1.4 Global Drugs For Travelers' Diarrhea (TD) Market Size by Type
- 1.4.1 Global Drugs For Travelers' Diarrhea (TD) Market Size Overview by Type (2021-2032)
- 1.4.2 Global Drugs For Travelers' Diarrhea (TD) Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Drugs For Travelers' Diarrhea (TD) Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Drugs For Travelers' Diarrhea (TD) Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Drugs For Travelers' Diarrhea (TD) Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Drugs For Travelers' Diarrhea (TD) Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Drugs For Travelers' Diarrhea (TD) Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Drugs For Travelers' Diarrhea (TD) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Drugs For Travelers' Diarrhea (TD) Industry Trends
- 2.2 Drugs For Travelers' Diarrhea (TD) Industry Drivers
- 2.3 Drugs For Travelers' Diarrhea (TD) Industry Opportunities and Challenges
- 2.4 Drugs For Travelers' Diarrhea (TD) Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Drugs For Travelers' Diarrhea (TD) Revenue (2021-2026)
- 3.2 Global Top Players by Drugs For Travelers' Diarrhea (TD) Sales (2021-2026)
- 3.3 Global Top Players by Drugs For Travelers' Diarrhea (TD) Price (2021-2026)
- 3.4 Global Drugs For Travelers' Diarrhea (TD) Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Drugs For Travelers' Diarrhea (TD) Major Company Production Sites & Headquarters
- 3.6 Global Drugs For Travelers' Diarrhea (TD) Company, Product Type & Application
- 3.7 Global Drugs For Travelers' Diarrhea (TD) Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Drugs For Travelers' Diarrhea (TD) Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Drugs For Travelers' Diarrhea (TD) Players Market Share by Revenue in 2025
- 3.8.3 2025 Drugs For Travelers' Diarrhea (TD) Tier 1, Tier 2, and Tier 3
4 Drugs For Travelers' Diarrhea (TD) Regional Status and Outlook
- 4.1 Global Drugs For Travelers' Diarrhea (TD) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Drugs For Travelers' Diarrhea (TD) Historic Market Size by Region
- 4.2.1 Global Drugs For Travelers' Diarrhea (TD) Sales in Volume by Region (2021-2026)
- 4.2.2 Global Drugs For Travelers' Diarrhea (TD) Sales in Value by Region (2021-2026)
- 4.2.3 Global Drugs For Travelers' Diarrhea (TD) Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Drugs For Travelers' Diarrhea (TD) Forecasted Market Size by Region
- 4.3.1 Global Drugs For Travelers' Diarrhea (TD) Sales in Volume by Region (2027-2032)
- 4.3.2 Global Drugs For Travelers' Diarrhea (TD) Sales in Value by Region (2027-2032)
- 4.3.3 Global Drugs For Travelers' Diarrhea (TD) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Drugs For Travelers' Diarrhea (TD) by Application
- 5.1 Drugs For Travelers' Diarrhea (TD) Market by Application
- 5.1.1 Adults
- 5.1.2 Children
- 5.2 Global Drugs For Travelers' Diarrhea (TD) Market Size by Application
- 5.2.1 Global Drugs For Travelers' Diarrhea (TD) Market Size Overview by Application (2021-2032)
- 5.2.2 Global Drugs For Travelers' Diarrhea (TD) Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Drugs For Travelers' Diarrhea (TD) Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Drugs For Travelers' Diarrhea (TD) Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Drugs For Travelers' Diarrhea (TD) Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Drugs For Travelers' Diarrhea (TD) Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Drugs For Travelers' Diarrhea (TD) Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Drugs For Travelers' Diarrhea (TD) Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Sun Pharmaceutical Industries Ltd.
- 6.1.1 Sun Pharmaceutical Industries Ltd. Company Information
- 6.1.2 Sun Pharmaceutical Industries Ltd. Business Overview
- 6.1.3 Sun Pharmaceutical Industries Ltd. Drugs For Travelers' Diarrhea (TD) Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Sun Pharmaceutical Industries Ltd. Drugs For Travelers' Diarrhea (TD) Product Portfolio
- 6.1.5 Sun Pharmaceutical Industries Ltd. Recent Developments
- 6.2 Johnson & Johnson
- 6.2.1 Johnson & Johnson Company Information
- 6.2.2 Johnson & Johnson Business Overview
- 6.2.3 Johnson & Johnson Drugs For Travelers' Diarrhea (TD) Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Johnson & Johnson Drugs For Travelers' Diarrhea (TD) Product Portfolio
- 6.2.5 Johnson & Johnson Recent Developments
- 6.3 Bayer AG
- 6.3.1 Bayer AG Company Information
- 6.3.2 Bayer AG Business Overview
- 6.3.3 Bayer AG Drugs For Travelers' Diarrhea (TD) Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Bayer AG Drugs For Travelers' Diarrhea (TD) Product Portfolio
- 6.3.5 Bayer AG Recent Developments
- 6.4 Valneva SE
- 6.4.1 Valneva SE Company Information
- 6.4.2 Valneva SE Business Overview
- 6.4.3 Valneva SE Drugs For Travelers' Diarrhea (TD) Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Valneva SE Drugs For Travelers' Diarrhea (TD) Product Portfolio
- 6.4.5 Valneva SE Recent Developments
- 6.5 Perrigo Company Plc
- 6.5.1 Perrigo Company Plc Company Information
- 6.5.2 Perrigo Company Plc Business Overview
- 6.5.3 Perrigo Company Plc Drugs For Travelers' Diarrhea (TD) Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Perrigo Company Plc Drugs For Travelers' Diarrhea (TD) Product Portfolio
- 6.5.5 Perrigo Company Plc Recent Developments
- 6.6 Norgine
- 6.6.1 Norgine Company Information
- 6.6.2 Norgine Business Overview
- 6.6.3 Norgine Drugs For Travelers' Diarrhea (TD) Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Norgine Drugs For Travelers' Diarrhea (TD) Product Portfolio
- 6.6.5 Norgine Recent Developments
- 6.7 Immuron
- 6.7.1 Immuron Company Information
- 6.7.2 Immuron Business Overview
- 6.7.3 Immuron Drugs For Travelers' Diarrhea (TD) Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Immuron Drugs For Travelers' Diarrhea (TD) Product Portfolio
- 6.7.5 Immuron Recent Developments
- 6.8 COSMO PHARMACEUTICALS
- 6.8.1 COSMO PHARMACEUTICALS Company Information
- 6.8.2 COSMO PHARMACEUTICALS Business Overview
- 6.8.3 COSMO PHARMACEUTICALS Drugs For Travelers' Diarrhea (TD) Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 COSMO PHARMACEUTICALS Drugs For Travelers' Diarrhea (TD) Product Portfolio
- 6.8.5 COSMO PHARMACEUTICALS Recent Developments
- 6.9 Bausch Health Companies Inc.
- 6.9.1 Bausch Health Companies Inc. Company Information
- 6.9.2 Bausch Health Companies Inc. Business Overview
- 6.9.3 Bausch Health Companies Inc. Drugs For Travelers' Diarrhea (TD) Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Bausch Health Companies Inc. Drugs For Travelers' Diarrhea (TD) Product Portfolio
- 6.9.5 Bausch Health Companies Inc. Recent Developments
7 North America by Country
- 7.1 North America Drugs For Travelers' Diarrhea (TD) Sales by Country
- 7.1.1 North America Drugs For Travelers' Diarrhea (TD) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Drugs For Travelers' Diarrhea (TD) Sales by Country (2021-2026)
- 7.1.3 North America Drugs For Travelers' Diarrhea (TD) Sales Forecast by Country (2027-2032)
- 7.2 North America Drugs For Travelers' Diarrhea (TD) Market Size by Country
- 7.2.1 North America Drugs For Travelers' Diarrhea (TD) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Drugs For Travelers' Diarrhea (TD) Market Size by Country (2021-2026)
- 7.2.3 North America Drugs For Travelers' Diarrhea (TD) Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Drugs For Travelers' Diarrhea (TD) Sales by Country
- 8.1.1 Europe Drugs For Travelers' Diarrhea (TD) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Drugs For Travelers' Diarrhea (TD) Sales by Country (2021-2026)
- 8.1.3 Europe Drugs For Travelers' Diarrhea (TD) Sales Forecast by Country (2027-2032)
- 8.2 Europe Drugs For Travelers' Diarrhea (TD) Market Size by Country
- 8.2.1 Europe Drugs For Travelers' Diarrhea (TD) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Drugs For Travelers' Diarrhea (TD) Market Size by Country (2021-2026)
- 8.2.3 Europe Drugs For Travelers' Diarrhea (TD) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Drugs For Travelers' Diarrhea (TD) Sales by Country
- 9.1.1 Asia-Pacific Drugs For Travelers' Diarrhea (TD) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Drugs For Travelers' Diarrhea (TD) Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Drugs For Travelers' Diarrhea (TD) Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Drugs For Travelers' Diarrhea (TD) Market Size by Country
- 9.2.1 Asia-Pacific Drugs For Travelers' Diarrhea (TD) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Drugs For Travelers' Diarrhea (TD) Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Drugs For Travelers' Diarrhea (TD) Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Drugs For Travelers' Diarrhea (TD) Sales by Country
- 10.1.1 South America Drugs For Travelers' Diarrhea (TD) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Drugs For Travelers' Diarrhea (TD) Sales by Country (2021-2026)
- 10.1.3 South America Drugs For Travelers' Diarrhea (TD) Sales Forecast by Country (2027-2032)
- 10.2 South America Drugs For Travelers' Diarrhea (TD) Market Size by Country
- 10.2.1 South America Drugs For Travelers' Diarrhea (TD) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Drugs For Travelers' Diarrhea (TD) Market Size by Country (2021-2026)
- 10.2.3 South America Drugs For Travelers' Diarrhea (TD) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Drugs For Travelers' Diarrhea (TD) Sales by Country
- 11.1.1 Middle East and Africa Drugs For Travelers' Diarrhea (TD) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Drugs For Travelers' Diarrhea (TD) Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Drugs For Travelers' Diarrhea (TD) Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Drugs For Travelers' Diarrhea (TD) Market Size by Country
- 11.2.1 Middle East and Africa Drugs For Travelers' Diarrhea (TD) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Drugs For Travelers' Diarrhea (TD) Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Drugs For Travelers' Diarrhea (TD) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Drugs For Travelers' Diarrhea (TD) Value Chain Analysis
- 12.1.1 Drugs For Travelers' Diarrhea (TD) Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Drugs For Travelers' Diarrhea (TD) Production Mode & Process
- 12.2 Drugs For Travelers' Diarrhea (TD) Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Drugs For Travelers' Diarrhea (TD) Distributors
- 12.2.3 Drugs For Travelers' Diarrhea (TD) Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst